This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Population Health Investment Valuation
Is PHIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PHIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate PHIC's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PHIC's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PHIC?
Key metric: As PHIC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for PHIC. This is calculated by dividing PHIC's market cap by their current
earnings.
What is PHIC's PE Ratio?
PE Ratio
31.5x
Earnings
US$6.89m
Market Cap
US$217.13m
PHIC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: PHIC is expensive based on its Price-To-Earnings Ratio (31.5x) compared to the US Capital Markets industry average (27.2x)
Price to Earnings Ratio vs Fair Ratio
What is PHIC's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
PHIC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
31.5x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PHIC's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.